| 臺大學術典藏 |
2021-12-01T02:30:18Z |
Invasive amebiasis as an emerging parasitic disease in patients with human immunodeficiency virus type 1 infection in Taiwan
|
CHIEN-CHING HUNG; Deng H.-Y.; Hsiao W.-H.; Hsieh S.-M.; Hsiao C.-F.; Chen M.-Y.; Chang S.-C.; Su K.-E. |
| 臺大學術典藏 |
2021-12-01T02:30:18Z |
Dose reduction for the management of indinavir-related toxicity in human immunodeficiency virus type 1-infected patients in Taiwan: Clinical and pharmacokinetic assessment
|
Pan S.-C.; Hsieh S.-M.; CHIEN-CHING HUNG; Huang P.-F.; Chen M.-Y.; Chang S.-C. |
| 臺大學術典藏 |
2021-12-01T02:30:17Z |
Herpes zoster in HIV-1-infected patients in the era of highly active antiretroviral therapy: A prospective observational study
|
CHIEN-CHING HUNG; Hsiao C.-F.; Wang J.-L.; Chen M.-Y.; Hsieh S.-M.; Sheng W.-H.; Chang S.-C. |
| 臺大學術典藏 |
2021-12-01T02:30:16Z |
Endemic fungal infections caused by Cryptococcus neoformans and Penicillium marneffei in patients infected with human immunodeficiency virus and treated with highly active anti-retroviral therapy
|
Sun H.-Y.; Chen M.-Y.; Hsiao C.-F.; Hsieh S.-M.; CHIEN-CHING HUNG; Chang S.-C. |
| 臺大學術典藏 |
2021-12-01T02:30:15Z |
Higher seroprevalence of Entamoeba histolytica infection is associated with human immunodeficiency virus type 1 infection in Taiwan
|
Tsai J.-J.; Sun H.-Y.; Ke L.-Y.; Tsai K.-S.; Chang S.-Y.; Hsieh S.-M.; Hsiao C.-F.; Yen J.-H.; CHIEN-CHING HUNG; Chang S.-C. |
| 臺大學術典藏 |
2021-12-01T02:30:13Z |
Improved survival of persons with human immunodeficiency virus type 1 infection in the era of highly active antiretroviral therapy in Taiwan
|
CHIEN-CHING HUNG; Hsiao C.-F.; Chen M.-Y.; Hsieh S.-M.; Chang S.-Y.; Sheng W.-H.; Sun H.-Y.; Chang S.-C. |
| 臺大學術典藏 |
2021-12-01T02:30:07Z |
Osteonecrosis in patients with human immunodeficiency virus type 1 infection in Taiwan
|
Ho Y.-C.; Shih T.T.F.; Lin Y.-H.; Hsiao C.-F.; Chen M.-Y.; Hsieh S.-M.; Sheng W.-H.; Sun H.-Y.; CHIEN-CHING HUNG; Chang S.-C. |
| 臺大學術典藏 |
2021-12-01T02:30:04Z |
Seroprevalence of viral hepatitis and infectious complications among human immunodeficiency virus-infected injection drug users at a referral hospital
|
Liang S.-H.; Lo Y.-C.; Lin H.-H.; Chang S.-Y.; Chen M.-Y.; Hsieh S.-M.; Sheng W.-H.; Sun H.-Y.; CHIEN-CHING HUNG; Chang S.-C. |
| 臺大學術典藏 |
2021-12-01T02:29:11Z |
Estimated risk of cardiovascular disease among the HIV-positive patients aged 40 years or older in Taiwan
|
Wu P.-Y.; Chen M.-Y.; Sheng W.-H.; Hsieh S.-M.; Chuang Y.-C.; Cheng A.; Pan S.-C.; Wu U.-I.; Chang H.-Y.; Luo Y.-Z.; Yang S.-P.; Zhang J.-Y.; Sun H.-Y.; CHIEN-CHING HUNG |
| 臺大學術典藏 |
2021-12-01T02:29:06Z |
Effect of a hepatitis a vaccination campaign during a hepatitis a outbreak in Taiwan, 2015-2017: A modeling study
|
Lin K.-Y.; Sun H.-Y.; Chen Y.-H.; Lo Y.-C.; Hsieh S.-M.; Sheng W.-H.; Chuang Y.-C.; Pan S.-C.; Cheng A.; CHIEN-CHING HUNG; Fang C.-T.; Chang S.-C. |
| 臺大學術典藏 |
2021-12-01T02:29:06Z |
Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real-world effectiveness and safety in Taiwan
|
Liu C.-H.; Liu C.-J.; CHIEN-CHING HUNG; Hsieh S.-M.; Su T.-H.; Sun H.-Y.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-09-27T05:32:43Z |
Evolution of SARS-CoV-2 neutralizing antibody in an HIV-positive patient with COVID-19
|
Liu W.-D.; Hung C.-C.; Wang J.-T.; Tsai M.-J.; Kuo P.-H.; Chao T.-L.; Hsieh S.-M.; WANG-HUEI SHENG; Chen Y.-C.; Chang S.-Y.; Chang S.-C. |
| 臺大學術典藏 |
2021-09-27T05:32:42Z |
Participation in cancer screening among people living with HIV at a university hospital
|
Wu P.-Y.; Sun H.-Y.; Chen M.-Y.; WANG-HUEI SHENG; Hsieh S.-M.; Chuang Y.-C.; Chang H.-Y.; Luo Y.-Z.; Zhang J.-Y.; Hung C.-C. |
| 臺大學術典藏 |
2021-09-27T05:32:39Z |
Evolution of estimated glomerular filtration rate in human immunodeficiency virus and hepatitis C virus-coinfected patients receiving sofosbuvir-based direct-acting antivirals and antiretroviral therapy
|
Liu C.-H.; Sun H.-Y.; Hsieh S.-M.; Liu W.-C.; WANG-HUEI SHENG; Liu C.-J.; Su T.-H.; Tseng T.-C.; Chen P.-J.; Hung C.-C.; Kao J.-H. |
| 臺大學術典藏 |
2021-09-04T06:12:40Z |
Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: A matched cohort study
|
Sheng W.-H.; Hung C.-C.; JIA-HORNG KAO; Chang S.-Y.; Chen M.-Y.; Hsieh S.-M.; Chen P.-J.; Chang S.-C. |
| 臺大學術典藏 |
2021-09-04T06:11:58Z |
Differential clinical and virologic impact of hepatitis B virus genotypes B and C on HIV-coinfected patients receiving lamivudine-containing highly active antiretroviral therapy
|
Sheng W.-H.; Hung C.-C.; Chang S.-Y.; Liu C.-J.; Chen M.-Y.; Hsieh S.-M.; JIA-HORNG KAO; Chen P.-J.; Chang S.-C. |
| 臺大學術典藏 |
2021-09-04T06:11:21Z |
Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naive Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study
|
Liu C.-H.; Sheng W.-H.; Sun H.-Y.; Hsieh S.-M.; Lo Y.-C.; Liu C.-J.; Su T.-H.; Yang H.-C.; Liu W.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T05:17:06Z |
Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection
|
Liu C.-H.; Sun H.-Y.; Liu C.-J.; Sheng W.-H.; Hsieh S.-M.; Lo Y.-C.; Liu W.-C.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T05:16:40Z |
Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real-world effectiveness and safety in Taiwan
|
Liu C.-H.; Liu C.-J.; Hung C.-C.; Hsieh S.-M.; Su T.-H.; Sun H.-Y.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-08-27T06:48:57Z |
Skin rash related to once-daily boosted darunavir-containing antiretroviral therapy in HIV-infected Taiwanese: incidence and associated factor
|
KUAN-YIN LIN; Cheng C.-Y.; Yang C.-J.; Tsai M.-S.; Hsieh S.-M.; Sun H.-Y.; Sheng W.-H.; Chen M.-Y.; Chang S.-Y.; Cheng S.-H.; Hung C.-C. |
| 臺大學術典藏 |
2021-08-27T06:48:54Z |
Incidence of acute hepatitis A among HIV-positive patients during an outbreak among MSM in Taiwan: Impact of HAV vaccination
|
Chen G.-J.; KUAN-YIN LIN; Sun H.-Y.; Sheng W.-H.; Hsieh S.-M.; Huang Y.-C.; Cheng A.; Liu W.-C.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-27T06:48:53Z |
Serological responses to revaccination with hepatitis A virus (HAV) vaccines among HIV-positive individuals whose anti-HAV antibody waned after primary vaccination
|
Chen G.-J.; Sun H.-Y.; KUAN-YIN LIN; Cheng A.; Huang Y.-C.; Hsieh S.-M.; Sheng W.-H.; Liu W.-C.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-27T06:48:53Z |
Serologic responses and effectiveness of hepatitis A vaccination among human immunodeficiency virus–positive individuals during the outbreak of acute hepatitis A
|
KUAN-YIN LIN; Hsieh S.-M.; Sun H.-Y.; Lo Y.-C.; Sheng W.-H.; Chuang Y.-C.; Cheng A.; Pan S.-C.; Chen G.-J.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-27T06:48:52Z |
Serological responses to revaccination against HBV in HIV-positive patients born in the era of nationwide neonatal HBV vaccination
|
Huang Y.-C.; Hsieh S.-M.; Sheng W.-H.; Huang Y.-S.; KUAN-YIN LIN; Chen G.-J.; Yang S.-P.; Liu W.-C.; Su Y.-C.; Sun H.-Y.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-27T06:48:52Z |
Comparable serologic responses to 2 different combinations of inactivated hepatitis A virus vaccines in HIV-positive patients during an acute hepatitis A outbreak in Taiwan
|
KUAN-YIN LIN; Hsieh S.-M.; Sheng W.-H.; Lo Y.-C.; Chuang Y.-C.; Cheng A.; Pan S.-C.; Chen G.-J.; Sun H.-Y.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-27T06:48:51Z |
Impact of antiretroviral therapy containing tenofovir disoproxil fumarate on the survival of patients with HBV and HIV coinfection
|
Tsai W.-C.; Hsu W.-T.; Liu W.-D.; Sun H.-Y.; Chuang Y.-C.; Huang Y.-S.; Cheng A.; KUAN-YIN LIN; Huang Y.-C.; Chen G.-J.; Huang S.-H.; Sheng W.-H.; Hsieh S.-M.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-27T06:48:49Z |
Effect of a hepatitis a vaccination campaign during a hepatitis a outbreak in Taiwan, 2015-2017: A modeling study
|
KUAN-YIN LIN; Sun H.-Y.; Chen Y.-H.; Lo Y.-C.; Hsieh S.-M.; Sheng W.-H.; Chuang Y.-C.; Pan S.-C.; Cheng A.; Hung C.-C.; Fang C.-T.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-27T06:48:48Z |
Impact of initiation of combination antiretroviral therapy according to the WHO recommendations on the survival of HIV-positive patients in Taiwan
|
Liu W.-D.; Tsai W.-C.; Hsu W.-T.; Shih M.-C.; Chen M.-Y.; Sun H.-Y.; Hsieh S.-M.; Sheng W.-H.; Chuang Y.-C.; Cheng A.; KUAN-YIN LIN; Huang Y.-S.; Huang S.-H.; Huang Y.-C.; Chen G.-J.; Wu P.-Y.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-25T01:53:17Z |
Skin rash related to once-daily boosted darunavir-containing antiretroviral therapy in HIV-infected Taiwanese: incidence and associated factor
|
KUAN-YIN LIN; Cheng C.-Y.; Yang C.-J.; Tsai M.-S.; Hsieh S.-M.; Sun H.-Y.; Sheng W.-H.; Chen M.-Y.; Chang S.-Y.; Cheng S.-H.; Hung C.-C. |
| 臺大學術典藏 |
2021-08-25T01:53:12Z |
Incidence of acute hepatitis A among HIV-positive patients during an outbreak among MSM in Taiwan: Impact of HAV vaccination
|
Chen G.-J.; KUAN-YIN LIN; Sun H.-Y.; Sheng W.-H.; Hsieh S.-M.; Huang Y.-C.; Cheng A.; Liu W.-C.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-25T01:53:11Z |
Serologic responses and effectiveness of hepatitis A vaccination among human immunodeficiency virus–positive individuals during the outbreak of acute hepatitis A
|
KUAN-YIN LIN; Hsieh S.-M.; Sun H.-Y.; Lo Y.-C.; Sheng W.-H.; Chuang Y.-C.; Cheng A.; Pan S.-C.; Chen G.-J.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-25T01:53:11Z |
Comparable serologic responses to 2 different combinations of inactivated hepatitis A virus vaccines in HIV-positive patients during an acute hepatitis A outbreak in Taiwan
|
KUAN-YIN LIN; Hsieh S.-M.; Sheng W.-H.; Lo Y.-C.; Chuang Y.-C.; Cheng A.; Pan S.-C.; Chen G.-J.; Sun H.-Y.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-25T01:53:11Z |
Serological responses to revaccination with hepatitis A virus (HAV) vaccines among HIV-positive individuals whose anti-HAV antibody waned after primary vaccination
|
Chen G.-J.; Sun H.-Y.; KUAN-YIN LIN; Cheng A.; Huang Y.-C.; Hsieh S.-M.; Sheng W.-H.; Liu W.-C.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-25T01:53:10Z |
Serological responses to revaccination against HBV in HIV-positive patients born in the era of nationwide neonatal HBV vaccination
|
Huang Y.-C.; Hsieh S.-M.; Sheng W.-H.; Huang Y.-S.; KUAN-YIN LIN; Chen G.-J.; Yang S.-P.; Liu W.-C.; Su Y.-C.; Sun H.-Y.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-25T01:53:09Z |
Impact of antiretroviral therapy containing tenofovir disoproxil fumarate on the survival of patients with HBV and HIV coinfection
|
Tsai W.-C.; Hsu W.-T.; Liu W.-D.; Sun H.-Y.; Chuang Y.-C.; Huang Y.-S.; Cheng A.; KUAN-YIN LIN; Huang Y.-C.; Chen G.-J.; Huang S.-H.; Sheng W.-H.; Hsieh S.-M.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-25T01:53:06Z |
Effect of a hepatitis a vaccination campaign during a hepatitis a outbreak in Taiwan, 2015-2017: A modeling study
|
KUAN-YIN LIN; Sun H.-Y.; Chen Y.-H.; Lo Y.-C.; Hsieh S.-M.; Sheng W.-H.; Chuang Y.-C.; Pan S.-C.; Cheng A.; Hung C.-C.; Fang C.-T.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-25T01:53:04Z |
Impact of initiation of combination antiretroviral therapy according to the WHO recommendations on the survival of HIV-positive patients in Taiwan
|
Liu W.-D.; Tsai W.-C.; Hsu W.-T.; Shih M.-C.; Chen M.-Y.; Sun H.-Y.; Hsieh S.-M.; Sheng W.-H.; Chuang Y.-C.; Cheng A.; KUAN-YIN LIN; Huang Y.-S.; Huang S.-H.; Huang Y.-C.; Chen G.-J.; Wu P.-Y.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-24T08:23:36Z |
Serological survey in close contacts with a confirmed case of H7N9 influenza in Taiwan
|
Hsieh S.-M.; YU-SHAN HUANG; Chang S.-Y.; Lin P.-H.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-24T08:23:33Z |
Impact of antiretroviral therapy containing tenofovir disoproxil fumarate on the survival of patients with HBV and HIV coinfection
|
Tsai W.-C.; Hsu W.-T.; Liu W.-D.; Sun H.-Y.; Chuang Y.-C.; YU-SHAN HUANG; Cheng A.; Lin K.-Y.; Huang Y.-C.; Chen G.-J.; Huang S.-H.; Sheng W.-H.; Hsieh S.-M.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-24T08:23:33Z |
Serological responses to revaccination against HBV in HIV-positive patients born in the era of nationwide neonatal HBV vaccination
|
Huang Y.-C.; Hsieh S.-M.; Sheng W.-H.; YU-SHAN HUANG; Lin K.-Y.; Chen G.-J.; Yang S.-P.; Liu W.-C.; Su Y.-C.; Sun H.-Y.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-24T08:23:30Z |
Seroepidemiology of the human herpesvirus 8 infection among people living with HIV in Taiwan, 2014–2018
|
Tsai M.-J.; Sun H.-Y.; Hsieh S.-M.; Sheng W.-H.; Chuang Y.-C.; YU-SHAN HUANG; Huang S.-H.; Su L.-H.; Su Y.-C.; Liu W.-C.; Chang S.-Y.; Hung C.-C. |
| 臺大學術典藏 |
2021-08-24T08:23:29Z |
Impact of initiation of combination antiretroviral therapy according to the WHO recommendations on the survival of HIV-positive patients in Taiwan
|
Liu W.-D.; Tsai W.-C.; Hsu W.-T.; Shih M.-C.; Chen M.-Y.; Sun H.-Y.; Hsieh S.-M.; Sheng W.-H.; Chuang Y.-C.; Cheng A.; Lin K.-Y.; YU-SHAN HUANG; Huang S.-H.; Huang Y.-C.; Chen G.-J.; Wu P.-Y.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-24T08:23:28Z |
Reversal of Viral Latency and Induction of Gag-Specific T-Cell Responses in HIV-1-Infected Adults Through Cyclic Treatment Interruption of Rosuvastatin: A Proof-of-Concept Study
|
Hsieh S.-M.; Pan S.-C.; YU-SHAN HUANG; Chang S.-C. |
| 臺大學術典藏 |
2021-08-24T08:23:28Z |
Safety and immunogenicity of a Recombinant Stabilized Prefusion SARS-CoV-2 Spike Protein Vaccine (MVC[sbnd]COV1901) Adjuvanted with CpG 1018 and Aluminum Hydroxide in healthy adults: A Phase 1, dose-escalation study
|
Hsieh S.-M.; Liu W.-D.; YU-SHAN HUANG; Lin Y.-J.; Hsieh E.-F.; Lian W.-C.; Chen C.; Janssen R.; Shih S.-R.; Huang C.-G.; Tai I.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-24T08:23:26Z |
A cross-sectional seroprevalence for COVID-19 among healthcare workers in a tertially care hospital in Taiwan
|
Pan S.-C.; YU-SHAN HUANG; Hsieh S.-M.; Chen Y.-C.; Chang S.-Y.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-20T07:25:54Z |
Seroepidemiology of the human herpesvirus 8 infection among people living with HIV in Taiwan, 2014–2018
|
Tsai M.-J.; Sun H.-Y.; Hsieh S.-M.; Sheng W.-H.; YU-CHUNG CHUANG; Huang Y.-S.; Huang S.-H.; Su L.-H.; Su Y.-C.; Liu W.-C.; Chang S.-Y.; Hung C.-C. |
| 臺大學術典藏 |
2021-08-20T07:25:53Z |
Participation in cancer screening among people living with HIV at a university hospital
|
Wu P.-Y.; Sun H.-Y.; Chen M.-Y.; Sheng W.-H.; Hsieh S.-M.; YU-CHUNG CHUANG; Chang H.-Y.; Luo Y.-Z.; Zhang J.-Y.; Hung C.-C. |
| 臺大學術典藏 |
2021-08-20T07:25:53Z |
Healthcare-associated carbapenem-resistant Klebsiella pneumoniae bloodstream infections: Risk factors, mortality, and antimicrobial susceptibility, 2017–2019
|
Hsu J.-Y.; YU-CHUNG CHUANG; Wang J.-T.; Chen Y.-C.; Hsieh S.-M. |
| 臺大學術典藏 |
2021-08-20T07:10:56Z |
Participation in cancer screening among people living with HIV at a university hospital
|
Wu P.-Y.; HSIN-YUN SUN; Chen M.-Y.; Sheng W.-H.; Hsieh S.-M.; Chuang Y.-C.; Chang H.-Y.; Luo Y.-Z.; Zhang J.-Y.; Hung C.-C. |
| 臺大學術典藏 |
2021-08-20T07:10:56Z |
Seroepidemiology of the human herpesvirus 8 infection among people living with HIV in Taiwan, 2014–2018
|
Tsai M.-J.; HSIN-YUN SUN; Hsieh S.-M.; Sheng W.-H.; Chuang Y.-C.; Huang Y.-S.; Huang S.-H.; Su L.-H.; Su Y.-C.; Liu W.-C.; Chang S.-Y.; Hung C.-C. |
